Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

J Appl Physiol (April 15, 2002). doi:10.1152/japplphysiol.00027.2002
This Article
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
93/2/569    most recent
00027.2002v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Piquard, F.
Right arrow Articles by Geny, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Piquard, F.
Right arrow Articles by Geny, B.

Articles in PresS, published online ahead of print April 15, 2002
J Appl Physiol, 10.1152/jap.00027.2002
Submitted on January 14, 2002
Accepted on April 10, 2002

Hormonal, Renal and Hemodynamic Responses to Acute Neutral Endopeptidase Inhibition in Chronic, Stable Heart Transplant Patients

Francois Piquard1*, Ruddy Richard2, Anne Charloux2, Stephane Doutreleau2, Thierry Hannedouche3, Gabrielle Brandenberger4, and Bernard Geny1

1 Faculte de Medecine, Institut de Physiologie, Strasbourg, France; Hopitaux Universitaires, Service d'Explorations Fonctionnelles et de l'Exercice, Strasbourg, France
2 Hopitaux Universitaires, Service d'Explorations Fonctionnelles et de l'Exercice, Strasbourg, France; Faculte de Medecine, Institut de Physiologie, Strasbourg, France
3 Hopitaux Universitaires, Service de Nephrologie et d'Hemodialyse, Strasbourg, France
4 Faculte de Medecine, Institut de Physiologie, Strasbourg, France

* To whom correspondence should be addressed. E-mail: Francois.Piquard{at}physio-ulp.u-strasbg.fr.

We investigated the hemodynamic, renal and hormonal responses to neutral endopeptidase inhibition (NEP) during a 6 hour, double-blind, randomized, placebo controlled study in seven chronic, stable heart-transplant patients. Baseline characteristics were similar during both experiments and no significant changes were observed after placebo. NEP-inhibition increased circulating endothelin (from 2.01 ± 0.1 to 2.90 ± 0.2 pmol/L, P<0.01), ANP from 21.5 ± 2.7 to 29.6 ± 3.7 pmol/L, P<0.01) and its second messenger cyclic guanosine monophosphate (cGMP). Noteworthy, systemic blood pressure did not increase. Renal plasma flow and glomerular filtration rate remained unmodified after NEP-inhibition. Filtration fraction (33 ± 13 %), diuresis (196 ± 62%), and natriuresis (315 ± 105 %) increased significantly in relation with ANP and cGMP. A strong inverse relationship was observed between excreted cGMP and sodium reabsorption (r = -0.71, P<0.0001). Thus, despite significantly increasing endothelin, NEP-inhibition did not adversely influence systemic or renal hemodynamics in transplant patients. ANP, possibly through a tubular action, enhances the natriuresis observed after NEP-inhibition.




This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
B. Geny, A. Charloux, G. Brandenberger, and F. Piquard
Despite cardiac denervation, atrial natriuretic peptides possess a cardiac sympathoinhibitory effect after heart transplantation
J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1417 - 1418.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. Trebbien, L. Klarskov, M. Olesen, J. J. Holst, R. D. Carr, and C. F. Deacon
Neutral endopeptidase 24.11 is important for the degradation of both endogenous and exogenous glucagon in anesthetized pigs
Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E431 - E438.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1966 by the American Physiological Society.